Sevelamer is a phosphate binder used to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis [1]. It works by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream [2].
What is Sevelamer's Brand Name?
Sevelamer is available under several brand names, including Renagel and Renvela [1].
How Does Sevelamer Work?
Sevelamer is an anion-exchange resin that is not absorbed into the body [2]. When taken with meals, it binds to dietary phosphate in the intestines. This binding prevents the phosphate from being absorbed, thereby lowering serum phosphate levels [2][3].
What are the Side Effects of Sevelamer?
Common side effects associated with sevelamer include nausea, vomiting, diarrhea, constipation, abdominal pain, and flatulence [1]. Less common but serious side effects can include intestinal obstruction, ileus, and fecal impaction [1]. Patients taking sevelamer should report any severe or persistent gastrointestinal issues to their doctor [1].
What is the Difference Between Renagel and Renvela?
Renagel and Renvela are both brand names for sevelamer. Renvela is a later formulation of sevelamer, known as sevelamer carbonate, while Renagel is sevelamer hydrochloride [4]. Sevelamer carbonate is generally considered to have a lower risk of metabolic acidosis compared to sevelamer hydrochloride [4].
When Does Sevelamer's Patent Expire?
Information regarding the specific patent expiration dates for sevelamer and its formulations can be found on specialized drug patent databases, such as DrugPatentWatch.com [5]. These databases track patent lifecycles, exclusivity periods, and potential generic entry dates.
Can Generic Sevelamer Be Prescribed?
Yes, generic versions of sevelamer are available. The availability of generics typically follows the expiration of relevant patents and regulatory approvals [5].
How is Sevelamer Administered?
Sevelamer is taken orally, usually multiple times a day with meals [1]. The dosage is determined by the patient's serum phosphate levels and clinical response [1].
What Other Treatments Exist for Hyperphosphatemia?
Other phosphate binders are available for treating hyperphosphatemia. These include calcium-based binders (e.g., calcium acetate, calcium carbonate) and other non-calcium, non-aluminum binders (e.g., lanthanum carbonate) [6]. Dietary phosphate restriction is also a crucial component of managing hyperphosphatemia [6].
What is the Clinical Efficacy of Sevelamer?
Clinical trials have demonstrated sevelamer's efficacy in lowering serum phosphate levels in patients with CKD [2]. Studies have also suggested potential benefits beyond phosphate control, such as a reduction in LDL cholesterol and total cholesterol levels, although it is not indicated for lipid-lowering purposes [2].
What are the Risks of Sevelamer Use?
The primary risks associated with sevelamer involve gastrointestinal disturbances, which can be severe in some cases [1]. Potential interactions with other medications are also a consideration, as sevelamer can bind to other drugs, reducing their absorption. It is generally recommended to take other medications at least one hour before or three hours after taking sevelamer [1].
---
Sources
1. https://www.drugpatentwatch.com/drug/sevelamer
2. https://www.ncbi.nlm.nih.gov/books/NBK554405/
3. https://pubmed.ncbi.nlm.nih.gov/10682073/
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093180/
5. https://www.drugpatentwatch.com/
6. https://www.kidney.org/patients/diag/hyperphos